Wnt modulating biologic (OncoMed/Bayer Schering Pharma)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NameWnt modulating biologic (OncoMed/Bayer Schering Pharma)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionWingless type MMTV integration site family protein modulators
TargetsWingless type MMTV integration site family protein
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesGermany
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMereo Biopharma
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMereo BiopharmaBayer Schering Pharma AG
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A